Veterinary Healthcare Coverage

Feed And Animal Nutrition Market Definition And Segments

Feed and animal nutrition refers to the diet and dietary management of domesticated animals to ensure their health, growth, and productivity. This involves understanding and optimizing the nutrient content and balance in feed to meet specific animal needs while considering factors such as species, age, weight, and activity level. The main product types of feed and animal nutrition are amino acids, vitamins, minerals, enzymes, fish oils and nutrition lipids, eubiotics, carotenoids, and others. Amino acid refers to a vital nutrient that is a building block of protein, essential for the growth and health of animals. For various species, including poultry, swine, ruminants, pets, and others, it is administered orally, topically, and in injections for applications such as veterinarians, animal feed manufacturers, households, farms, and others. The feed and animal nutrition market covered in this report is segmented – 1) By Product Type: Amino Acids, Vitamins, Minerals, Enzymes, Fish Oils And Nutrition Lipids, Eubiotics, Carotenoids, Other Product Types 2) By Species: Poultry, Swine, Ruminants, Pets, Other Species 3) By Administrative Method: Oral, Topical, Injection 4) By Application: Veterinarians, Animal Feed Manufacturers, Households, Farms, Other Applications The feed and animal nutrition market size has grown strongly in recent years. It will grow from $499.76 billion in 2023 to $533.73 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to a rise in livestock farming, growth of meat and dairy consumption, rise in incomes especially in developing countries, increased migration to urban areas, favorable subsidies, and supportive policies for the agricultural sector, and global population. The feed and animal nutrition market size is expected to see strong growth in the next few years. It will grow to $698.61 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to growing consumer awareness about animal health and food safety, increased focus on sustainable and eco-friendly farming practices, growing aquaculture industry, rising pet ownership and the humanization of pets, and enhanced regulatory frameworks promoting animal welfare and food safety standards. Major trends in the forecast period include the use of advanced data analytics and AI to create tailored feed formulations, the use of alternative and sustainable feed ingredients, the development of feeds with added health benefits, such as probiotics, prebiotics, and immune-boosting ingredients, integration of automation and Internet of Things (IoT) technologies in feed production and distribution, and application of genetic research to improve feed conversion ratios.

Rising Global Consumption of Meat, Dairy, And Poultry Products Boosts Feed And Animal Nutrition Market Growth

The increased consumption of meat, dairy, and poultry products is expected to propel the growth of the feed and animal nutrition market going forward. Meat, dairy, and poultry products refer to animal-derived food items, including beef, pork, chicken, eggs, milk, and cheese. The increasing consumption of meat, dairy, and poultry products can be attributed to the rising global population, changing dietary habits, and growing demand for protein-rich foods. The development of feed and animal nutrition solutions enhances the quality and productivity of meat, dairy, and poultry products, which contributes to sustainable farming practices, animal welfare, and overall food safety standards. For instance, in June 2023, according to a report published by the Food and Agriculture Organization of the United Nations (FAO), a US-based agency that specializes in promoting food security, sustainable agriculture, and rural development, global meat production is projected to rise from 356.9 million metric tons in 2021 to 363.9 million metric tons in 2023, reflecting a 1.96% increase. Specifically, global bovine meat production is expected to increase from 74.9 million metric tons in 2021 to 76.1 million metric tons in 2023. Additionally, global poultry meat output is forecast to reach 138.2 million metric tons in 2021 to 142.7 million metric tons in 2023. Similarly, global ovine meat output is forecast to be 16.8 million metric tons in 2023, reflecting a 1% year-on-year increase. Therefore, increased consumption of meat, dairy, and poultry products is driving the feed and animal nutrition market. Major companies operating in the feed and animal nutrition market are Cargill Incorporated, Archer Daniels Midland Company, BASF SE, Tyson Foods Inc., Evonik Industries AG, Charoen Pokphand Foods Public Company Limited, Land O'Lakes Inc., Koninklijke DSM N.V., De Heus Animal Nutrition B.V., Nutreco N.V., Elanco Animal Health Incorporated, Wilbur-Ellis Company LLC, Alltech Inc., Royal Agrifirm Group B.V., ForFarmers N.V., Trouw Nutrition USA LLC, Kemin Industries Inc., Lallemand Inc., Phibro Animal Health Corporation, Balchem Corporation, Ridley Corporation Limited, Kent Nutrition Group Inc., Novus International Inc., Manna Pro Products LLC, Zinpro Corporation, Diamond V Mills Inc., Vita Plus Corporation, BIOMIN Holding GmbH, Hi-Pro Feeds LP

Innovative Sweetening Solutions Revolutionize Feed And Animal Nutrition Market

Major companies operating in the feed and animal nutrition markets are focused on developing innovative products, such as in-feed sweetening solutions designed to improve feed palatability and encourage feed intake during critical growth stages. In-feed sweetening solutions are additives used in animal feed to enhance its palatability and encourage consumption. These solutions often contain natural or artificial sweeteners to improve the taste of feed for livestock and pets. For instance, in November 2022, The Archer-Daniels-Midland Company (ADM), a US-based food processing and company, launched its SUCRAM range, an in-feed sweetening solution for livestock species. The range has two products such as SUCRAM M’I Sweet and SUCRAM Specifeek. These products are in-feed sweetening solutions specifically designed to improve the palatability of feed for young animals, particularly weanling pigs. These sweeteners aim to enhance feed intake and efficiency for producers while supporting animal health and well-being. These saccharin-free sweeteners have been tested in an in-vitro swine sweet taste receptor model and are intended to encourage feed intake during the transition from liquid to solid feed. The products may also optimize nutrient absorption, support gut health, and promote growth and performance in pigs during this stressful period.

ADM Strengthens Animal Nutrition Capabilities With Acquisition Of PT Trouw Nutrition Indonesia

In December 2023, The Archer-Daniels-Midland Company (ADM), a US-based food processing company, acquired PT Trouw Nutrition Indonesia for an undisclosed amount. The acquisition is expected to help Archer-Daniels-Midland Company enhance its capabilities and position in the animal nutrition industry, particularly in the Asia-Pacific region. PT Trouw Nutrition Indonesia is an Indonesia-based subsidiary of Nutreco, a provider of functional and nutritional solutions for livestock farming. Asia-Pacific was the largest region in the feed and animal nutrition market in 2023. The regions covered in the feed and animal nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the feed and animal nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The feed and animal nutrition market consists of sales of feed additives, premixes, and supplements designed to improve animal health and productivity. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The feed and animal nutrition research report is one of a series of new reports from The Business Research Company that provides feed and animal nutrition market statistics, including the feed and animal nutrition industry's global market size, regional shares, competitors with a feed and animal nutrition market share, detailed feed and animal nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the feed and animal nutrition industry. This feed and animal nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pet Herbal Supplements Market Definition And Segments

Pet herbal supplements are natural dietary products for pets, such as dogs, cats, or horses, to support their health and well-being. These supplements typically contain a combination of herbal extracts, vitamins, minerals, and other nutrients chosen for their potential benefits in promoting pet health. The main products of pet herbal supplements are omega-3 fatty acids, probiotics and prebiotics, multivitamins and minerals, cannabidiol oil (CBD), proteins and peptides, and others. Omega-3 fatty acids are essential polyunsaturated fats, including ALA, EPA, and DHA, that are crucial for various bodily functions and are obtained primarily from fish, plant sources, and supplements. It includes dosage forms such as tablets and capsules, gummies and chewable, powders, liquids, and others, for animal types such as dogs, cats, horses, and others. It is used for applications such as digestive support, immunity support, skin and coat, calming or stress or anxiety, joint health support, kidney health, liver health, respiratory health, and others, with distribution channels including online, and offline. The pet herbal supplements market covered in this report is segmented – 1) By Product: Omega 3 Fatty Acids, Probiotics And Prebiotics, Multivitamins And Minerals, Cannabidiol Oil (CBD), Proteins And Peptides, Other Products 2) By Dosage Form: Tablets And Capsules, Gummies And Chewable, Powders, Liquids, Other Dosage Forms 3) By Animal Type: Dogs, Cats, Horses, Other Animals 4) By Application: Digestive Support, Immunity Support, Skin And Coat, Calming Or Stress Or Anxiety, Joint Health Support, Kidney Health, Liver Health, Respiratory Health, Other Applications 5) By Distribution Channel: Online, Offline The pet herbal supplements market size has been grown rapidly in recent years. It will grow from $0.99 billion in 2023 to $1.12 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing awareness of pet health, humanization of pets, veterinary recommendations, regulatory support, and consumer preferences for natural products. The pet herbal supplements market size is expected to see rapid growth in the next few years. It will grow to $1.87 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to continued growth in pet ownership, the aging pet population, e-commerce expansion, personalized nutrition, and environmental sustainability. Major trends in the forecast period include advanced extraction techniques, nanotechnology applications, digital health monitoring, AI-driven formulation optimization, and personalized supplements.

Rising Pet Expenditure Fuels Growth In Pet Herbal Supplements Market

The rising pet expenditure is expected to propel the growth of the pet herbal supplements market going forward. Pet expenditure refers to costs related to pet food, supplies and medicines, veterinarian care, live animal purchases, and other services. The increase in pet expenditure is driven by the humanization of pets, leading to higher spending on premium products and services and advancements in pet healthcare requiring more costly treatments. The rise in pet expenditure is boosting the pet herbal supplements market as owners increasingly seek natural, high-quality health products to ensure their pets' well-being and longevity. For instance, in November 2023, according to a report by American Pet Products Association, Inc., a US-based not-for-profit industry association, the U.S. pet industry expenditure was $147.0 billion in 2023, up from $136.8 billion in 2022. Therefore, the rising pet expenditure is driving the growth of the pet herbal supplements market. Major companies operating in the pet herbal supplements market are Merck & Co. Inc., C.H. Boehringer Sohn AG & Co. KG, Zoetis Inc., Elanco Animal Health Incorporated, Virbac, Dechra Pharmaceuticals plc, Vetoquinol, Nutramax Laboratories, Nulo Pet Food, Ceva Animal Health, Healthy Paws Herbal Labs, Zesty Paws, PetHonesty, Only Natural Pet, Petlab Co., Honest Paws, Vet's Best Friend, Ark Naturals, Herbsmith, NaturVet, Vital Pet Life, Paw Naturals

Innovative Canine Supplements Enhancing Pet Health And Well-being

Major companies operating in the pet herbal supplements market are focusing on developing innovative products, such as canine supplements, to serve customers better and gain a competitive edge in the market. A canine supplement is an over-the-counter or prescribed product that provides additional vitamins, minerals, enzymes, amino acids, and herbs to address various health issues in dogs, such as skin disorders, joint problems, and overall well-being. For instance, in July 2023, Badlands Ranch, a leading US-based pet nutrition brand, launched Super20, a canine superfood powder designed to support dogs' overall well-being. This comprehensive supplement includes natural ingredients such as mushrooms, milk thistle, and ashwagandha to promote energy, mobility, coat health, mood upliftment, and smooth digestion. It addresses common concerns such as joint stiffness, gut health, stress management, and immune support, providing an effortless way to enhance the quality of life for beloved furry companions.

General Mills Expands Into Pet Supplements With Acquisition Of Fera Pets Inc.

In November 2023, General Mills, Inc., a US-based manufacturer and marketer of branded processed consumer foods, acquired Fera Pets Inc. for an undisclosed amount. The acquisition represents General Mills’ first step into the pet supplement category to expand its presence in pets. Fera Pets Inc. is a US-based vet-founded pet supplement company. North America was the largest region in the pet herbal supplements market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet herbal supplements market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pet herbal supplements market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The pet herbal supplements market consists of sales of herbal extracts, joint support supplements, and digestive aids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The pet herbal supplements market research report is one of a series of new reports from The Business Research Company that provides pet herbal supplements market statistics, including the pet herbal supplements industry global market size, regional shares, competitors with pet herbal supplements market share, detailed pet herbal supplements market segments, market trends, and opportunities, and any further data you may need to thrive in the pet herbal supplements industry. These pet herbal supplements market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Veterinary Excipients Market Definition And Segments

Veterinary excipients are inactive substances used in the formulation of veterinary medications. These substances serve as the vehicle or medium for the active ingredients in the medication, aiding in the manufacturing process and ensuring the drug's stability, bioavailability, and overall effectiveness. Veterinary excipients are essential components of animal medications, playing crucial roles in the formulation, efficacy, safety, and usability of veterinary pharmaceutical products. The main chemical group of veterinary excipients are polymers, alcohols, lipids, mineral salts, and others. Polymers are large molecules made up of repeating structural units called monomers, linked together by covalent bonds. For various animals including companion and production animals for functions such as fillers, binders, disintegrants, glidants, lubricants, bulking agents, buffering agents, tonicity adjusting agents, and preservatives for applications such as biologics, pharmaceuticals, and medicated feed additives. The veterinary excipients market covered in this report is segmented – 1) By Chemical Group: Polymers, Alcohols, Lipids, Mineral Salts, Other Chemical Groups 2) By Animal Type: Companion Animals, Production Animals 3) By Functionality: Fillers, Binders, Disintegrants, Glidants, Lubricants, Bulking Agents, Buffering Agents, Tonicity Adjusting Agents, Preservatives, Other Functionalities 4) By Application: Biologics, Pharmaceuticals, Medicated Feed Additives The veterinary excipients market size has grown strongly in recent years. It will grow from $0.89 billion in 2023 to $0.94 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased pet ownership, advancements in veterinary medicine, growth in demand for animal protein, rise pet healthcare expenditure, and expansion of animal healthcare infrastructure. The veterinary excipients market size is expected to see strong growth in the next few years. It will grow to $1.18 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing focus on animal welfare, rise in pet insurance coverage, growing prevalence of zoonotic diseases, expansion of veterinary pharmaceuticals market, and emergence of novel excipients. Major trends in the forecast period include personalized medicine for animals, adoption of natural and organic excipients, integration of digital health solutions, innovation in veterinary health industry, and technological advancements.

Rising Zoonotic Diseases Drive Growth In The Veterinary Excipients Market

The increase in zoonotic diseases is expected to propel the growth of the veterinary excipients market going forward. Zoonotic diseases are illnesses that can be transmitted from animals to humans. Zoonotic diseases are increasing due to habitat encroachment, climate change, intensive farming, wildlife trade, deforestation, poor sanitation, and ecosystem changes, necessitating urgent action. Veterinary excipients formulate medications to treat zoonotic diseases, ensuring the active ingredients' stability, efficacy, and safety for animal health. For instance, in November 2023, according to European Union One Health, an Italy-based food safety authority, in 2022, there was a more than 600% increase in locally acquired human West Nile virus infections, a mosquito-borne disease, compared to 2021. Therefore, the increase in zoonotic diseases is driving the veterinary excipients market. Major companies operating in the veterinary excipients market are Archer Daniels Midland Company, Badische Anilin- und Soda-Fabrik AG, Evonik Industries AG, DuPont de Nemours Inc., Clariant AG, Azelis India Private Limited, Lubrizol India Private Limited, Croda International Plc, Ashland Inc., JRS PHARMA GmbH & Co. KG, Vantage Specialty Chemicals, Colorcon Inc., Seppic SA, Spectrum Laboratory Products Inc., Gattefossé SAS, Quality Chemicals S.L., IOI Oleo GmbH, Lipoid LLC, Synergy API Private Limited, SSS Pharmachem Private Limited

Innovative Solutions Revolutionize The Veterinary Excipients Market

Major companies operating in the veterinary excipients market are developing innovative products, such as VitiPure excipients, to cater to the growing demand for veterinary health. VitiPure excipients are a line of high-purity excipients designed to enhance the stability and solubility of active pharmaceutical ingredients (APIs) across various applications. For instance, in October 2023, Clariant, a Switzerland-based specialty chemical company, launched a range of VitiPure excipients to offer versatile support for a range of API formulations and administration methods, including delicate substances such as mRNA vaccines and biologics. Notably, VitiPure O 80 Superior is a top-tier, low microbial load Polysorbate 80, prized for its minimal impurities and colorless, odorless nature.

Domes Pharma Group Acquired SentrX Animal Care Expanding Veterinary Healthcare Portfolio

In August 2023, Domes Pharma Group, a France-based pharmaceutical company, acquired Sentrx Animal Care Inc. for an undisclosed amount. This acquisition marks a significant step for Dômes Pharma in expanding its global leadership in veterinary ophthalmology and establishing a foothold for its therapeutic product franchises in North America. SentrX Animal Care Inc. is a US-based company manufacturing veterinary products, including veterinary excipients. North America was the largest region in the veterinary excipients market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The veterinary excipients market consist of sales of antioxidants, humectants, solvents, and lipid-based excipients. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary excipients research report is one of a series of new reports from The Business Research Company that provides veterinary excipients market statistics, including the veterinary excipients industry's global market size, regional shares, competitors with a veterinary excipients market share, detailed veterinary excipients market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary excipients industry. This veterinary excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Veterinary Orthopedic Medicine Market Definition And Segments

Veterinary orthopedic medicine is a specialized field within veterinary medicine focused on diagnosing, treating, and preventing disorders and injuries of the musculoskeletal system in animals. It encompasses a range of conditions such as fractures, arthritis, congenital deformities, and soft tissue injuries and involves various treatments, including surgical interventions, physical therapy, and rehabilitation to restore mobility and functionality in animals. The main products of veterinary orthopedic medicine are biologics, viscosupplements, and pharmaceuticals. Biologics are substances from living cells or organisms that treat diseases or injuries. The various animal types involved are canine, feline, equine, cattle, swine, and others. The multiple applications involved are osteoarthritis, degenerative joint disease, joint inflammation or pain, and others which is used by veterinary hospitals, veterinary clinics, other end users The veterinary orthopedic medicine market covered in this report is segmented – 1) By Product: Biologics, Viscosupplements, Pharmaceuticals 2) By Animal Type: Canine, Feline, Equine, Cattle, Swine, Other Animal Types 3) By Application: Osteoarthritis, Degenerative Joint Disease, Joint Inflammation Or Pain, Other Applications 4) By End-use: Veterinary Hospitals, Veterinary Clinics, Other End Users The veterinary orthopedic medicine market size has grown strongly in recent years. It will grow from $3.38 billion in 2023 to $3.69 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to emergence of regenerative medicine, telemedicine integration, increasing number of veterinary orthopedic specialists, rise in the adoption of viscosupplementation products, and improving animal health awareness. The veterinary orthopedic medicine market size is expected to see strong growth in the next few years. It will grow to $5.26 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising prevalence of osteoarthritis, increasing adoption of pet insurance, high prevalence of obesity in companion animals, increasing pet ownership, rising pet expenditure. Major trends in the forecast period include hybrid implants, advanced materials, regenerative medicine, 3D imaging, computerized tomography (CT).

Rising Incidence Of Pet Orthopedic Diseases Fueling Market Expansion

The increasing incidence of pet orthopedic diseases is expected to propel the growth of the veterinary orthopedic medicine market going forward. Pet orthopedic diseases refer to conditions affecting the musculoskeletal system of companion animals, particularly dogs and cats. The increasing incidence of pet orthopedic diseases can be attributed to factors such as breed predispositions, rising rates of obesity, and environmental factors such as inadequate exercise and poor nutrition. Veterinary orthopedic medicine plays a crucial role in diagnosing, treating, and managing orthopedic diseases in pets, helping to alleviate pain, restore mobility, and improve the overall quality of life. For instance, in July 2021, according to the National Institute of Health, osteoarthritis affected about 20% of all adult dogs and more than 90% of dogs over five years old in North America. Therefore, the increasing incidence of pet orthopedic diseases is driving the growth of the veterinary orthopedic medicine market. Major companies operating in the veterinary orthopedic medicine market are AmerisourceBergen Corporation, Johnson & Johnson, EVEROST Inc., Zoetis Inc., Elanco Animal Health, Integra lifesciences, Ceva Sante Animale, Virbac SA, STERIS Animal Health, Merck Animal Health (Merck & Co. Inc.), Veterinary Orthopedic Implants, American Regent, Bimeda U.S., B. Braun Melsungen AG, Coveto SA, Biogenesis Bago, Vetoquinol S.A., Avante Animal Health, Hyalogic LLC, Hester Biosciences, Petline Sa, Sklar Instruments, GerMedUSA, RWD Life Science, Orthomed (UK) Ltd., BioMedtrix LLC, IMEX Veterinary Inc.

Advancements in Anatomically Shaped Casts for Veterinary Orthopedic Care

Major companies operating in the veterinary orthopedic medicine market focus on developing innovative solutions, such as anatomically shaped casts, to eliminate pressure sores and improve the standard of care for pets with fractures. Anatomically shaped casts are specialized orthopedic devices designed to conform to the natural contours of an animal's body, providing effective immobilization and support for healing fractures, sprains, or other orthopedic injuries. For instance, in November 2021, OrthoPets Veterinary, a US-based manufacturer of veterinary orthotic and prosthetic (VOP) devices, launched a new line of biodegradable anatomically shaped casts designed to eliminate pressure sores and improve the standard of care for pets with fractures. The anatomically shaped splints cover various casting treatments, from full leg casts to paw or toe injuries, offering a modern and effective alternative to traditional casting methods. These anatomically shaped casts represent a significant advancement in veterinary orthopedic medicine, offering a safer, more comfortable, and more efficient solution for treating animal fractures and injuries.

Movora Expands Portfolio Through Acquisition of IMEX Veterinary, Inc

In December 2021, Movora, a US-based veterinary MedTech company, acquired IMEX Veterinary Inc. for an undisclosed amount. Through this acquisition, Movora entered a new niche segment within surgical products and expanded its portfolio. IMEX Veterinary, Inc is a China-based company that manufactures veterinary orthopedic products. North America was the largest region in the veterinary orthopedic medicine market in 2023. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary orthopedic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The veterinary orthopedic medicine market includes revenues earned by entities by providing services such as diagnosing, treating, and preventing musculoskeletal disorders and injuries in animals. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary orthopedic medicine market also includes sales of intramedullary devices, external fixation devices, and joint implants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary orthopedic medicine market research report is one of a series of new reports from The Business Research Company that provides veterinary orthopedic medicine market statistics, including veterinary orthopedic medicine industry global market size, regional shares, competitors with veterinary orthopedic medicine market share, detailed veterinary orthopedic medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary orthopedic medicine industry. This veterinary orthopedic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Veterinary Rapid Test Market Definition And Segments

A veterinary rapid test is a diagnostic tool used in veterinary medicine to quickly detect the presence of specific pathogens, diseases, or conditions in animals. These tests are designed to provide fast and accurate results, often within minutes to a few hours, allowing for timely decision-making in the treatment and management of animal health. Veterinary rapid tests play a crucial role in animal healthcare by enabling prompt diagnosis and treatment, improving outcomes, and aiding in controlling and preventing disease spread among animal populations. The main product types of veterinary rapid tests are rapid test kits and rapid test readers. Veterinary rapid test kits are specialized tools used for screening animals like cats, dogs, cattle, and bovines by placing a sample of a specimen on a device. The various animal types include companion animals, and production animals using various technologies such as immunoassays, and polymerase chain reaction (PCR). These are used in various applications such as viral diseases, bacterial diseases, parasitic diseases, allergies, and others, and also by various end-users such as veterinary hospitals and clinics, home care settings, and others. The veterinary rapid test market covered in this report is segmented – 1) By Product: Rapid Test Kits, Rapid Test Readers 2) By Animal Type : Companion Animal, Production Animal 3) By Technology: Immunoassays, Polymerase Chain Reaction(PCR) 4) By Application: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies, Other Applications 5) By End-User: Veterinary Hospitals And Clinics, Homecare Settings, Other End Users The veterinary rapid test market size has grown rapidly in recent years. It will grow from $0.72 billion in 2023 to $0.80 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to growth in veterinary rapid tests, rise in demand for rapid test diagnosis over other test, rise in adoption of pet insurance, increased demand for animal-based protein source, rise in numbers of veterinarians and veterinary visits. The veterinary rapid test market size is expected to see rapid growth in the next few years. It will grow to $1.24 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing pet ownership, increasing consumer awareness regarding scientific animal nutrition, increase in industrialized livestock production, increasing diagnostic testing of livestock diseases, increasing prevalence of zoonotic diseases in animals. Major trends in the forecast period include product innovation, advancements in biotechnology, demand for quick and accurate diagnostic solutions, innovative veterinary diagnostics, technological advancements in diagnostic technologies.

The Impact Of Rising Pet Ownership On The Veterinary Rapid Test Market

The increasing pet ownership is expected to propel the growth of the growth of the veterinary rapid test market going forward. Pet ownership refers to the relationship in which an individual or household takes responsibility for a pet animal's care, welfare, and maintenance. The increase in pet ownership can be attributed to social trends, urbanization, and a rise in young adults delaying parenthood. Veterinary rapid tests provide pet owners with timely and accurate diagnostic information, facilitating proactive healthcare management and ultimately promoting their animal companions' health, happiness, and longevity. For instance, according to The American Pet Products Association (APPA), a US-based organization, pet ownership in the United States rose from 67% of households owning a pet in 2021-2022 to 70%. Additionally, from 2023 to 2024, 66% of U.S. households owned a pet, which equates to 86.9 million households. Therefore, increasing pet ownership drives the veterinary rapid test market. Major companies operating in the veterinary rapid test market are Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN GmbH, Virbac Corp., Neogen Corporation , Antech Diagnostics Inc., Heska Corporation, Ring Biotechnology Co Ltd., Woodley Equipment Company Ltd., Prometheus Biosciences Inc., BioChek, Bionote Usa Inc., Agrolabo S.p.A., Shenzhen Bioeasy Biotechnology Co. Ltd., Fassisi GmbH, MEGACOR Diagnostik GmbH, Biopanda Reagents Ltd., Boster Biological Technology Co. Ltd., Swissavans AG, Secure Diagnostics Pvt. Ltd., Eurolyser Diagnostica GmbH

Revolutionizing Veterinary Diagnostics With The Emergence of AI-Based Rapid Tests In Veterinary Healthcare

Major companies operating in the veterinary rapid test market are developing advanced solutions such as AI-based rapid tests to enhance diagnostic accuracy and improve overall efficiency in veterinary healthcare. AI-based rapid tests represent a significant advancement in veterinary diagnostics, offering veterinarians powerful tools to expedite the diagnostic process, improve diagnostic accuracy, and ultimately enhance the quality of care provided to animals. For instance, in November 2023, Micron Agritech, an Ireland-based sustainable health company, launched the Micron Kit Fluke Test, an innovative AI-powered rapid test for liver fluke in livestock. This breakthrough solution allows farmers and veterinarians to quickly test animals on-site using their smartphones for both liver fluke (Fasciola hepatica) and rumen fluke (Calicophoron daubneyi) infections

Strategic Acquisition Of Zoetis Inc.'s Move Into At-Home Genetic Testing For Pets Through Basepaws Acquisition

In June 2022, Zoetis Inc., a US-based drug company, acquired Basepaws for an undisclosed amount. With this acquisition, Zoetis aligns with the growing trend of pet owners spending billions on their pets' health and the increasing popularity of animal at-home genetic testing. Basepaws is a US-based company offering rapid veterinary tests, including genetic screening tests for dogs and cats. North America was the largest region in the veterinary rapid test market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary rapid test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary rapid test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The veterinary rapid test market consists of sales of canine tests, feline tests, equine tests, and livestock tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary rapid test market research report is one of a series of new reports from The Business Research Company that provides veterinary rapid test market statistics, including veterinary rapid test industry global market size, regional shares, competitors with a veterinary rapid test market share, detailed veterinary rapid test market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary rapid test industry. This veterinary rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry

Veterinary Renal Disease Market Definition And Segments

Veterinary renal disease refers to a range of conditions that affect the kidneys of animals, leading to impaired kidney function. It disrupts the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues. The main types of veterinary renal disease are diagnosis and treatment. A diagnosis is a conclusion reached through medical evaluation, identifying a specific condition or disease affecting an individual's health. The animal types are canine, feline, bovine, equine, and others and the indications include renal failure, chronic kidney disease (CKD), renal cystitis, kidney stones, nephritis, and others. The route of administration is injectable and oral and distribution channels are pharmacies, pet specialty stores, e-commerce, and others. The veterinary renal disease market covered in this report is segmented – 1) By Type: Diagnosis, Treatment 2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types 3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications 4) By Route of Administration: Injectable, Oral 5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels The veterinary renal disease market size has grown strongly in recent years. It will grow from $14.55 billion in 2023 to $15.33 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to growing disease awareness initiatives, the shift in consumer preferences towards natural and organic pet food, increasing pet ownership rates globally, regulatory changes in veterinary pharmaceuticals, and growing awareness about pet health and nutrition. The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $20.36 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to the emergence of personalized veterinary medicine, expansion of telemedicine and remote monitoring in veterinary care, rise in veterinary clinical trials and research, adoption of blockchain technology for supply chain transparency in veterinary products, and integration of artificial intelligence and machine learning in veterinary diagnostics. Major trends in the forecast period include increasing demand for veterinary teleconsultations, the surge in customized pet nutrition plans, the growth of wearable health monitoring devices for pets, the expansion of veterinary telemedicine platforms, and the adoption of precision medicine in veterinary oncology.

Increasing Pet Ownership Fuels Growth In The Veterinary Renal Disease Market

The increased pet ownership is expected to propel the growth of the veterinary renal disease market going forward. Veterinary renal disease refers to conditions affecting the kidneys in animals, leading to impaired kidney function and potentially resulting in symptoms such as increased thirst, frequent urination, loss of appetite, and weight loss. The increasing veterinary renal disease is driven by longer pet lifespans, exposure to environmental toxins, dietary factors, and genetic predispositions. Veterinary renal disease treatments for pets typically involve dietary management, medication, and fluid therapy to alleviate symptoms, slow disease progression, and improve quality of life. For instance, in October 2022, according to Cooper Pet Care, a Netherlands-based mobile pet care platform, there will be approximately 145 million pet animals in the European Union, which includes Norway and Switzerland. This marks a rise of 5 million compared to the count in 2021, which stood at around 140 million pets. This population includes about 66 million dogs and 79 million cats. Therefore, increasing pet ownership is driving the growth of the veterinary renal disease market. Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic

Launch Of First Diagnostic Test For Early Detection Of Kidney Injury In Pets

Major companies operating in the veterinary renal disease market are focusing on developing technical advancements in treatment and diagnosis, such as novel diagnostic tests with the ability to detect kidney injury even when clinical signs may not be apparent. Diagnostic tests capable of detecting kidney injury with an aim to identify subtle changes in renal function or structure, facilitating early intervention to prevent progression to advanced stages of renal dysfunction. For instance, in June 2023, IDEXX Laboratories Inc., a US-based developer and manufacturer of veterinary products and services, launched the first veterinary diagnostic test for detecting kidney injury in cats and dogs. This test, known as the IDEXX Cystatin B Test, is designed to help veterinarians identify kidney injury before changes in kidney function become apparent, ultimately leading to better patient outcomes. The IDEXX Cystatin B Test will be integrated into test panels that assess renal health, providing valuable insights during an estimated two million patient visits annually.

Dechra Pharmaceuticals Acquires Piedmont Animal Health To Enhance Veterinary Product Pipeline

In July 2022, Dechra Pharmaceuticals plc, a UK-based developer of veterinary products, acquired Piedmont Animal Health LLC for $210 million. The acquisition adds strength and expertise to Dechra's existing product development resource and accelerates the provision of innovative solutions to veterinarians and pet owners in areas of unmet or underserved medical needs. Piedmont Animal Health LLC is a US-based provider of medicines for veterinary renal disease. North America was the largest region in the veterinary renal disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the veterinary renal disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The veterinary renal disease market consists of revenues earned by entities by providing services such as laboratory testing, imaging services, and fluid therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary renal disease market also includes sales of angiotensin receptor blockers, phosphate binders, omega-3 fatty acids, and antioxidants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The veterinary renal disease market research report is one of a series of new reports from The Business Research Company that provides veterinary renal disease market statistics, including veterinary renal disease industry global market size, regional shares, competitors with a veterinary renal disease market share, detailed veterinary renal disease market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary renal disease industry. This veterinary renal disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Zoonotic Disease Treatment Market Definition And Segments

Zoonotic disease treatment refers to the medical interventions and therapies aimed at diagnosing, managing, and preventing illnesses caused by pathogens transmitted between animals and humans. This treatment involves a combination of medication, vaccination, hygiene practices, and control measures to reduce transmission and mitigate the impact of these infections on both animal and human populations. The main types of diseases in zoonotic disease treatment are rabies, tuberculosis, malaria, leishmaniasis, Ebola virus disease, and others. Rabies is a viral disease that causes acute inflammation of the brain in humans and other mammals and is typically transmitted through the bite of an infected animal. The drug classes of zoonotic disease treatment are anti-fungal, anti-bacterial, antibiotics, and others and it is caused by various agents such as bacteria, virus, nematode, rodents, ticks, and others. The route of administration includes oral, topical, and others and it is distributed by channels such as hospital pharmacy, retail pharmacy, online pharmacy, and others. The zoonotic disease treatment market covered in this report is segmented – 1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types 2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes 3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents 4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations 5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels The zoonotic disease treatment market size has grown strongly in recent years. It will grow from $37.20 billion in 2023 to $39.71 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to the emergence of major zoonotic outbreaks, urbanization, and habitat encroachment, one health approach, increased surveillance and reporting, globalization, and increased travel and public awareness and education. The zoonotic disease treatment market size is expected to see strong growth in the next few years. It will grow to $52.26 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to climate change and environmental factors, government and international funding, advancements in medical technology, regulatory support and streamlined approvals, and collaborative research and development. Major trends in the forecast period include the development of broad-spectrum antivirals, strengthening global health infrastructure, advances in diagnostic technology, growth in vaccine development platforms, and focus on preventive measures.

Increased Demand For Animal Proteins Drives Growth In Zoonotic Disease Treatment Market

The increased demand for animal proteins is expected to propel the growth of the zoonotic disease treatment market going forward. Animal proteins are proteins derived from animal sources, such as meat, dairy, eggs, and fish, and contain all essential amino acids necessary for human health. The increased demand for animal proteins is due to the rising global population, higher income levels, urbanization, and growing awareness of the nutritional benefits of animal-based foods. Zoonotic disease treatments offer insights for managing diseases stemming from animal proteins, understanding transmission routes, developing effective therapies, and implementing preventive measures to mitigate public health risks. For instance, in July 2021, according to the report published by the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization, and the Food and Agriculture Organization, an Italy-based specialized agency, global consumption of meat proteins is forecast to surge by 14% by 2030, where availability of protein from various meat sources is expected to grow as beef by 5.9%, pork by 13.1%, poultry by 17.8%, and sheep meat by 15.7%. Therefore, the increased demand for animal proteins is driving the growth of the zoonotic disease treatment market. Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc., Heska Corporation

Product Development In Zoonotic Disease Treatment Through Vaccine Research And Development

Major companies operating in the zoonotic disease treatment market focus on developing innovative products, such as the tick-borne encephalitis (TBE) vaccine, to address the growing need for effective prevention and control of zoonotic diseases. The tick-borne encephalitis (TBE) vaccine is a preventive measure against the tick-borne encephalitis virus, transmitted to humans through tick bites. It stimulates the immune system to produce antibodies against the TBE virus, reducing the risk of developing the disease. For instance, in August 2021, Pfizer Inc., a US-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved TICOVAC, a tick-borne encephalitis (TBE) vaccine. TICOVAC is the only FDA-approved vaccine designed to safeguard adults and children in the United States against the TBE virus, particularly beneficial for those residing in or traveling to TBE-endemic regions.

Santé Animale Strengthens Presence In North America With Artemis Technologies Inc. Acquisition

In May 2022, Ceva Santé Animale, a France-based veterinary pharmaceutical company, acquired Artemis Technologies Inc. for an undisclosed amount. This strategic acquisition enhances Ceva's existing rabies portfolio and extensive expertise in producing oral rabies vaccines and overseeing vaccination campaigns for rabies across Europe and other regions. Artemis Technologies Inc. is a Canada-based provider of vaccines for zoonotic diseases. North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the zoonotic disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain The zoonotic disease treatment market consists of revenues earned by entities by providing services such as antimicrobial therapy, supportive care, vaccinations, and vector control. The market value includes the value of related goods sold by the service provider or included within the service offering. The zoonotic disease treatment market also includes sales of antimicrobial medications (antiparasitic, immunomodulators), diagnostic kits, and vector control products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The zoonotic disease treatment market research report is one of a series of new reports from The Business Research Company that provides zoonotic disease treatment market statistics, including zoonotic disease treatment industry global market size, regional shares, competitors with a zoonotic disease treatment market share, detailed zoonotic disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the zoonotic disease treatment industry. This zoonotic disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Animal Genetics Market Definition And Segments

Animal genetics refers to the practice of selective breeding of farm and companion animals by humans for specific benefits. This includes the use of genetic modification and selective breeding practices to increase the yield of animal-derived products. Animal genetics allows for the selection of desirable traits in livestock, such as higher milk yield, better meat quality, disease resistance, and improved growth rates. The main types of animal genetics are animal genetics products, genetic materials, and embryo. Animal genetics products include tools and technologies used to study and manipulate the genetic makeup of animals. The various services provided include genetic disease tests, DNA typing, genetic trait tests, and others for cattle, pigs, sheep and goats, companion animals, and other animals by different end users, such as veterinary hospitals and clinics, academic and research institutes, animal breeders, and pet owners. The animal genetics market covered in this report is segmented – 1) By Type: Animal Genetics Products, Genetic Materials, Embryo 2) By Service: Genetic Disease Tests, DNA Typing, Genetic Trait Tests, Other Services 3) By Animal Type: Cattle, Pigs, Sheep And Goats, Companion Animals, Other Animals 4) By End User: Veterinary Hospitals and Clinics, Academic And Research Institutes, Animal Breeders, Pet Owners The animal genetics market size has grown strongly in recent years. It will grow from $6.29 billion in 2023 to $6.76 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increasing demand for high-quality animal proteins and meat, government initiatives and funding support, increasing prevalence of genetic diseases, growing livestock populations, increasingly conscious of animal welfare. The animal genetics market size is expected to see strong growth in the next few years. It will grow to $9.11 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increased adoption of advanced genomic technologies, development of portable and cost-effective genetic testing solutions, increased demand for animal-derived products, increasing demand for better nutrition, the growing demand for animal-derived dietary supplements. Major trends in the forecast period include next-generation sequencing (NGS), techniques like CRISPR-Cas9 enable precise alterations to the genetic code, advanced genetic identification methods, including DNA typing, genetic disease tests, advances in reproductive technologies.

Rising Demand for Animal Protein Fuels Growth in the Animal Genetics Market

The increasing demand for animal protein is expected to propel the growth of the animal genetics market going forward. Animal protein refers to the protein derived from animal sources such as meat, poultry, fish, eggs, and dairy products. There is a growing preference for protein-rich diets, particularly in developed countries, driven by health consciousness, fitness trends, and cultural preferences. Animal genetics helps increase animal protein production by enabling the selection and breeding of animals with superior traits, such as higher muscle mass, disease resistance, and improved reproductive efficiency, leading to more efficient and productive livestock farming. For instance, according to revised data published in December 2023 by the Food and Agriculture Organization, an Italy-based specialized agency of the United Nations, global meat production increased steadily from 350 million tons in 2021 to 355 million tons in 2022. Therefore, the increasing demand for animal protein is driving the growth of the animal genetics market. Major companies operating in the animal genetics market are Zoetis Services LLC, CRV, Genus, Neogen Corporation, Groupe Grimaud, URUS Group LP, Cobb-Vantress Inc., Topigs Norsvin, Hendrix Genetics BV, Accelerated Genetics, Cogent Breeding, Alta Genetics Inc., ABS Global, Trans Ova Genetics, Embark Veterinary Inc., Tropical Bovine Genetics, EW Group, Wisdom Panel, VetGen, Animal Genetics Inc., Paw Print Genetics, Orivet, EasyDNA, Sandor Animal Biogenics Pvt. Ltd., SEK Genetics

Integration of Artificial Intelligence in Animal Genetics

Major companies operating in the animal genetics market are developing innovative platforms by integrating artificial intelligence (AI) to identify desirable traits more accurately and efficiently. AI is used to predict and detect genetic disorders at early stages, allowing for timely interventions and reducing the incidence of hereditary diseases in animals. For instance, in April 2022, Zoetis, a US-based animal health company, introduced its latest diagnostics innovation by adding artificial intelligence (AI) blood smear testing to its multi-purpose platform, Vetscan Imagyst. This technology uses deep machine learning AI to provide accurate and efficient blood smear analysis, supplementing complete blood count (CBC) results and helping veterinarians make better treatment decisions for animals with hematologic abnormalities. The AI-driven analysis in Vetscan Imagyst can clarify abnormalities, provide an estimated platelet count, verify white blood cell differentials, and identify and count polychromasia, among other details, all within minutes.

Zoetis Expands its portfolio of pet care products and services with Basepaws Portfolio

In June 2021, Zoetis, a US-based company that discovers and manufactures veterinary vaccines, medicines, and diagnostic products for livestock and companion animals, acquired Basepaws for an undisclosed amount. With this acquisition, Zoetis will offer innovative genetic testing solutions to pet owners, providing insights into their cats' ancestry, breed, and potential health risks. Basepaws is a US-based pet genetics company specializing in DNA testing for cats. North America was the largest region in the animal genetics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal genetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the animal genetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The animal genetics market includes revenues earned by entities by providing services such as health and performance testing, breed registry services, genome editing, and in vitro fertilization. The market value includes the value of related goods sold by the service provider or included within the service offering. The animal genetics market also includes sales of embryo transfer kits, veterinary diagnostic devices, performance tracking devices, health and disease testing kits, and genomic selection panels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The animal genetics market research report is one of a series of new reports from The Business Research Company that provides animal genetics market statistics, including the animal genetics industry global market size, regional shares, competitors with animal genetics market share, detailed animal genetics market segments, market trends, and opportunities, and any further data you may need to thrive in the animal genetics industry. These animal genetics market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.